» Authors » Bart N M van Berckel

Bart N M van Berckel

Explore the profile of Bart N M van Berckel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 217
Citations 7519
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stockbauer A, Beyer L, Huber M, Kreuzer A, Palleis C, Katzdobler S, et al.
Eur J Nucl Med Mol Imaging . 2023 Nov; 51(4):1023-1034. PMID: 37971501
Purpose: Metabolic network analysis of FDG-PET utilizes an index of inter-regional correlation of resting state glucose metabolism and has been proven to provide complementary information regarding the disease process in...
2.
Tuncel H, Visser D, Timmers T, Wolters E, Ossenkoppele R, van der Flier W, et al.
EJNMMI Res . 2023 Oct; 13(1):93. PMID: 37889456
Background: Dynamic PET imaging studies provide accurate estimates of specific binding, but also measure the relative tracer delivery (R), which is a proxy for relative cerebral blood flow (rCBF). Recently,...
3.
Coomans E, de Koning L, Rikken R, Verfaillie S, Visser D, den Braber A, et al.
Neurology . 2023 Sep; 101(19):e1850-e1862. PMID: 37748892
Background And Objectives: Recently, the US Food and Drug Administration approved the tau-binding radiotracer [F]flortaucipir and an accompanying visual read method to support the diagnostic process in cognitively impaired patients...
4.
van Engelen M, Verfaillie S, Dols A, Oudega M, Boellaard R, Golla S, et al.
EJNMMI Res . 2023 Jul; 13(1):71. PMID: 37493827
Background: Behavioural symptoms and frontotemporal hypometabolism overlap between behavioural variant of frontotemporal dementia (bvFTD) and primary psychiatric disorders (PPD), hampering diagnostic distinction. Voxel-wise comparisons of brain metabolism might identify specific...
5.
Verveen A, Verfaillie S, Visser D, Csorba I, Coomans E, Koch D, et al.
BMJ Open . 2023 Jul; 13(6):e072611. PMID: 37399444
Introduction: The risk factors for persistent fatigue and cognitive complaints after infection with SARS-CoV-2 and the underlying pathophysiology are largely unknown. Both clinical factors and cognitive-behavioural factors have been suggested...
6.
Schoonhoven D, Coomans E, Millan A, van Nifterick A, Visser D, Ossenkoppele R, et al.
Brain . 2023 Jun; 146(10):4040-4054. PMID: 37279597
Recent studies on Alzheimer's disease (AD) suggest that tau proteins spread through the brain following neuronal connections. Several mechanisms could be involved in this process: spreading between brain regions that...
7.
Huiskamp M, Yaqub M, van Lingen M, Pouwels P, de Ruiter L, Killestein J, et al.
Brain Commun . 2023 May; 5(3):fcad140. PMID: 37180993
Cognitive impairment occurs in 40-65% of persons with multiple sclerosis and may be related to alterations in glutamatergic and GABAergic neurotransmission. Therefore, the aim of this study was to determine...
8.
Visser D, Verfaillie S, Bosch I, Brouwer I, Tuncel H, Coomans E, et al.
Eur J Nucl Med Mol Imaging . 2023 Mar; 50(8):2409-2419. PMID: 36976303
Purpose: Tau pathology is associated with concurrent atrophy and decreased cerebral blood flow (CBF) in Alzheimer's disease (AD), but less is known about their temporal relationships. Our aim was therefore...
9.
Coomans E, Tomassen J, Ossenkoppele R, Tijms B, Lorenzini L, Ten Kate M, et al.
Brain . 2023 Mar; 146(9):3735-3746. PMID: 36892415
The amyloid cascade hypothesis has strongly impacted the Alzheimer's disease research agenda and clinical trial designs over the past decades, but precisely how amyloid-β pathology initiates the aggregation of neocortical...
10.
Muurling M, Badissi M, de Boer C, Legdeur N, Barkhof F, van Berckel B, et al.
BMC Geriatr . 2023 Mar; 23(1):129. PMID: 36882690
Background: Research assessing the relationship of physical activity and dementia is usually based on studies with individuals younger than 90 years of age. The primary aim of this study was...